Table 7.
B | ES | Wald | df | p | Odds ratio (OR) | Confidence interval (CI) | |||
---|---|---|---|---|---|---|---|---|---|
Min | Max | ||||||||
Model I: IPEDs use (total sample) | AAI (scores ≥21) | 0.366 | 0.127 | 8.330 | 1 | 0.004 | 1.443 | 1.125 | 1.850 |
N = 2,468 | SCS (scores <27) | −0.047 | 0.118 | 0.160 | 1 | 0.689 | 0.954 | 0.757 | 1.202 |
EAI (scores ≥24) | 1.003 | 0.200 | 25.247 | 1 | 0.000 | 2.726 | 1.843 | 4.030 | |
Age | 0.004 | 0.004 | 1.294 | 1 | 0.255 | 1.004 | 0.997 | 1.012 | |
Constant | −2.391 | 0.392 | 37.290 | 1 | 0.000 | 0.092 | |||
Model II: IPEDs use (men) N = 843 | AAI (scores ≥21) | 0.648 | 0.261 | 6.160 | 1 | 0.013 | 1.912 | 1.146 | 3.189 |
SCS (scores <27) | −0.092 | 0.212 | 0.187 | 1 | 0.665 | 0.912 | 0.602 | 1.382 | |
EAI (scores ≥24) | 0.801 | 0.309 | 6.699 | 1 | 0.010 | 2.227 | 1.215 | 4.084 | |
Age | −0.007 | 0.006 | 1.555 | 1 | 0.212 | 0.993 | 0.982 | 1.004 | |
Constant | −1.668 | 0.638 | 6.833 | 1 | 0.009 | 0.189 | |||
Model III: IPEDs use (women) N = 1,613 | AAI (scores ≥21) | 0.413 | 0.152 | 7.379 | 1 | 0.007 | 1.511 | 1.122 | 2.035 |
SCS (scores <27) | −0.078 | 0.145 | 0.286 | 1 | 0.593 | 0.925 | 0.697 | 1.229 | |
EAI (scores ≥24) | 1.100 | 0.267 | 17.019 | 1 | 0.000 | 3.003 | 1.781 | 5.063 | |
Age | 0.013 | 0.005 | 6.176 | 1 | 0.013 | 1.013 | 1.003 | 1.023 | |
Constant | −2.961 | 0.512 | 33.512 | 1 | 0.000 | 0.052 |
IPEDs use (0, not used; 1, used); problematic exercise (0, scores <24; 1, scores ≥24); AAI (0, scores <21; 1, scores ≥21); SCS (0, scores <27; 1, scores ≥27).
AAI, Appearance Anxiety Inventory; IPEDs, image- and performance-enhancing drug; SCS, Self-Compassion Scale.